[HTML][HTML] Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic …
…, T Lingscheid, P Tober-Lau, LA Meyer-Arndt… - Infection, 2021 - Springer
Purpose Adequate patient allocation is pivotal for optimal resource management in strained
healthcare systems, and requires detailed knowledge of clinical and virological disease …
healthcare systems, and requires detailed knowledge of clinical and virological disease …
[HTML][HTML] A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with …
C Kedor, H Freitag, L Meyer-Arndt, K Wittke… - Nature …, 2022 - nature.com
A subset of patients has long-lasting symptoms after mild to moderate Coronavirus disease
2019 (COVID-19). In a prospective observational cohort study, we analyze clinical and …
2019 (COVID-19). In a prospective observational cohort study, we analyze clinical and …
Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination
INTRODUCTION The clinical manifestations of COVID-19 vary from asymptomatic infection
to respiratory failure. Severe disease courses are primarily associated with advanced age, …
to respiratory failure. Severe disease courses are primarily associated with advanced age, …
[PDF][PDF] A time-resolved proteomic and prognostic map of COVID-19
…, M Kleinschmidt, KM Heim, B Millet, L Meyer-Arndt… - Cell systems, 2021 - cell.com
COVID-19 is highly variable in its clinical presentation, ranging from asymptomatic infection
to severe organ damage and death. We characterized the time-dependent progression of …
to severe organ damage and death. We characterized the time-dependent progression of …
[HTML][HTML] Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective …
…, S Zvorc, L Kretzler, LA Meyer-Arndt… - Clinical Microbiology …, 2021 - Elsevier
Objectives Dexamethasone has become the standard of care for severe coronavirus disease
2019 (COVID-19), but its virological impact is poorly understood. The objectives of this …
2019 (COVID-19), but its virological impact is poorly understood. The objectives of this …
[HTML][HTML] Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort
F Legler, L Meyer-Arndt, L Mödl, C Kedor… - …, 2023 - thelancet.com
Background Post-COVID-19 syndrome (PCS) is characterised by a wide range of symptoms,
primarily fatigue and exertion intolerance. While disease courses in the early months post-…
primarily fatigue and exertion intolerance. While disease courses in the early months post-…
[HTML][HTML] Inflammatory cytokines associated with multiple sclerosis directly induce alterations of neuronal cytoarchitecture in human neurons
L Meyer-Arndt, J Kerkering, T Kuehl, AG Infante… - Journal of Neuroimmune …, 2023 - Springer
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS)
coined by inflammation and neurodegeneration. The actual cause of the …
coined by inflammation and neurodegeneration. The actual cause of the …
[HTML][HTML] Post-COVID exercise intolerance is associated with capillary alterations and immune dysregulations in skeletal muscles
…, R Rust, F Legler, C Preusse, L Meyer-Arndt… - Acta Neuropathologica …, 2023 - Springer
The SARS-CoV-2 pandemic not only resulted in millions of acute infections worldwide, but
also in many cases of post-infectious syndromes, colloquially referred to as “long COVID”. …
also in many cases of post-infectious syndromes, colloquially referred to as “long COVID”. …
SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod
L Meyer-Arndt, J Braun, F Fauchere… - Journal of Neurology …, 2022 - jnnp.bmj.com
Background SARS-CoV-2 mRNA vaccination of healthy individuals is highly immunogenic
and protective against severe COVID-19. However, there are limited data on how disease-…
and protective against severe COVID-19. However, there are limited data on how disease-…
Cutting edge: Serum but not mucosal antibody responses are associated with pre-existing SARS-CoV-2 spike cross-reactive CD4+ T cells following BNT162b2 …
L Meyer-Arndt, T Schwarz, L Loyal, L Henze… - The Journal of …, 2022 - journals.aai.org
Advanced age is a main risk factor for severe COVID-19. However, low vaccination efficacy
and accelerated waning immunity have been reported in this age group. To elucidate age-…
and accelerated waning immunity have been reported in this age group. To elucidate age-…
